1. Home
  2. ATS vs SLNO Comparison

ATS vs SLNO Comparison

Compare ATS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATS
  • SLNO
  • Stock Information
  • Founded
  • ATS 1978
  • SLNO 1999
  • Country
  • ATS Canada
  • SLNO United States
  • Employees
  • ATS N/A
  • SLNO N/A
  • Industry
  • ATS
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ATS
  • SLNO Health Care
  • Exchange
  • ATS Nasdaq
  • SLNO Nasdaq
  • Market Cap
  • ATS 2.7B
  • SLNO 3.2B
  • IPO Year
  • ATS 2023
  • SLNO 2014
  • Fundamental
  • Price
  • ATS $28.77
  • SLNO $73.51
  • Analyst Decision
  • ATS Sell
  • SLNO Strong Buy
  • Analyst Count
  • ATS 2
  • SLNO 9
  • Target Price
  • ATS $30.50
  • SLNO $103.33
  • AVG Volume (30 Days)
  • ATS 153.1K
  • SLNO 744.8K
  • Earning Date
  • ATS 05-28-2025
  • SLNO 05-07-2025
  • Dividend Yield
  • ATS N/A
  • SLNO N/A
  • EPS Growth
  • ATS N/A
  • SLNO N/A
  • EPS
  • ATS N/A
  • SLNO N/A
  • Revenue
  • ATS $1,762,471,214.00
  • SLNO N/A
  • Revenue This Year
  • ATS N/A
  • SLNO N/A
  • Revenue Next Year
  • ATS $13.22
  • SLNO N/A
  • P/E Ratio
  • ATS N/A
  • SLNO N/A
  • Revenue Growth
  • ATS N/A
  • SLNO N/A
  • 52 Week Low
  • ATS $20.90
  • SLNO $36.93
  • 52 Week High
  • ATS $34.32
  • SLNO $80.99
  • Technical
  • Relative Strength Index (RSI)
  • ATS 54.97
  • SLNO 50.25
  • Support Level
  • ATS $27.68
  • SLNO $72.59
  • Resistance Level
  • ATS $30.68
  • SLNO $78.32
  • Average True Range (ATR)
  • ATS 1.09
  • SLNO 2.70
  • MACD
  • ATS 0.16
  • SLNO -0.63
  • Stochastic Oscillator
  • ATS 48.55
  • SLNO 32.52

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: